A Controlled Study to Evaluate the Effects of a Topical Cream on Symptoms of Arthritis, Joint, and Muscle Pain

NCT07767669 | Completed

• 1 other identifier: 20831
• Study Type: interventional
• Target: 80
• Locations: 1 country
• Sites: 1

Brief Summary

This is a randomized, triple-blind, controlled clinical trial evaluating the effects of Saje Pain Release Joint \& Arthritis Cream on symptoms of arthritis, joint pain, and muscle pain in adults aged 20-65. The trial is conducted virtually over seven days, with 80 participants randomized equally into an intervention arm (active topical cream) and a control arm (matched control product). Participants apply their assigned product three times daily to affected areas (knees, elbows, wrists, or ankles) and complete questionnaires at Baseline, 30 minutes after the first application, and at the end of Day 7. The primary objective is to assess changes in arthritis and musculoskeletal pain symptoms, while secondary objectives assess participants' perceptions of joint pain, stiffness, function, comfort, flexibility, mobility, and overall quality of life.

Conditions

Arthritis; Joint Pain; Muscle Pain; Musculoskeletal Pain; Joint Stiffness

Outcome Measures

Primary Outcomes (3)

• Change in symptoms of arthritis

  Assessed via self-reported numerical pain rating scale and the Musculoskeletal Health Questionnaire (MSK-HQ) validated questionnaire

  Baseline, 30 minutes after first application, and Day 7

• Change in symptoms of joint pain

  Assessed via self-reported numerical pain rating scale and the Musculoskeletal Health Questionnaire (MSK-HQ) validated questionnaire

  Baseline, 30 minutes after first application, and Day 7

• Change in symptoms of muscle pain

  Assessed via self-reported numerical pain rating scale and the Musculoskeletal Health Questionnaire (MSK-HQ) validated questionnaire

  Baseline, 30 minutes after first application, and Day 7

Secondary Outcomes (8)

• Change in self-reported joint pain

  Baseline, 30 minutes after first application, and Day 7

• Change in self-reported joint stiffness

  Baseline, 30 minutes after first application, and Day 7

• Change in self-reported joint function

  Baseline, 30 minutes after first application, and Day 7

• Change in self-reported joint comfort

  Baseline, 30 minutes after first application, and Day 7

• Change in self-reported flexibility

  Baseline, 30 minutes after first application, and Day 7

Study Arms (2)

Intervention (Saje Pain Release Joint & Arthritis Cream)

EXPERIMENTAL

Dietary Supplement: Intervention (Saje Pain Release Joint & Arthritis Cream)

Placebo Comparator

PLACEBO COMPARATOR

Dietary Supplement: Placebo Comparator

Interventions

Intervention (Saje Pain Release Joint & Arthritis Cream) DIETARY_SUPPLEMENT

40 participants apply a thin layer of the Saje Pain Release Joint \& Arthritis Cream to arthritis-affected areas (knees, elbows, wrists, ankles) three times daily (morning, afternoon, and evening) for seven days

Intervention (Saje Pain Release Joint & Arthritis Cream)

Placebo Comparator DIETARY_SUPPLEMENT

40 participants apply a matched control product (identical in appearance and consistency to the active product but without active ingredients such as L-menthol and balsam copaiba oil) to arthritis-affected areas three times daily (morning, afternoon, and evening) for seven days

Placebo Comparator

Eligibility Criteria

• Age: 20 Years - 65 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Be male or female
• Be aged 20-65
• Has experienced issues regarding all of the following in the past four weeks: symptoms of arthritis of the knees, elbows, wrists, or ankles
• joint pain and stiffness
• Self-reported issues must be at least 3 out of 10 in severity, with 1 being the least severe and 10 being the most
• Generally healthy - does not live with any uncontrolled chronic disease
• If taking oral over-the-counter supplements or herbal remedies targeted at symptoms of arthritis, joint and muscle pain, has been consistently taking these for at least 3 months prior to starting the study, and is willing to maintain this routine for the study duration
• Willing to avoid introducing any new forms of prescription medication or supplements that target symptoms of arthritis, joint and muscle pain for the study duration
• Resides in the United States
• Willing to maintain their current diet, sleep pattern, and activity levels for the duration of the trial

You may not qualify if:

• Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders
• Anyone with any allergies or sensitivities to any of the study product ingredients
• Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period)
• Symptoms occurring in a joint that has been surgically repaired
• Anyone unwilling to follow the study protocol
• Anyone who identifies as having sensitive skin
• Anyone with any history of skin cancer or any pre-cancerous lesions on their skin
• Anyone with a history of substance abuse
• Anyone who is currently a smoker or has been a smoker in the past 3 months
• Currently partaking in another research study or will be partaking in any other research study at any point during this study's duration
• Anyone with chronic skin conditions (e.g., dermatitis, eczema, psoriasis)
• Anyone who currently takes prescription pain relief to manage their symptoms

Sponsors & Collaborators

• Saie Beauty: lead
• Citruslabs: collaborator

Study Sites (1)

Citruslabs

Las Vegas, Nevada, 89101, United States

Location

MeSH Terms

Conditions

Arthritis; Arthralgia; Myalgia; Musculoskeletal Pain

Interventions

Methods

Condition Hierarchy (Ancestors)

Joint Diseases; Musculoskeletal Diseases; Pain; Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Muscular Diseases; Neuromuscular Diseases; Nervous System Diseases

Intervention Hierarchy (Ancestors)

Investigative Techniques

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: TRIPLE
• Who Masked: PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: August 11, 2026
• First Posted: August 17, 2026
• Study Start: February 1, 2026
• Primary Completion: May 31, 2026
• Study Completion: May 31, 2026
• Last Updated: August 17, 2026

Record last verified: 2026-08

Locations

US (1)